HLS Therapeutics: Top 10 Undervalued Drug Manufacturers Industry Stocks (HLS)
HLS Therapeutics is now ranked among the top 10 undervalued stocks in the Drug Manufacturers industry on the Toronto Stock Exchange or TSX Venture Exchange.
- A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company
- Valuation methodology provided by Stockcalc (see below)
Drug Manufacturers: Major, global pharmaceutical manufacturers offering a broad and diverse line of drug and healthcare products; industry leaders that have made a significant commitment to the research and development of a long pipeline of drugs.
Stocks in this category are held primarily for capital appreciation.
| Symbol | Name | Close Price ($) | Valuation ($) | Difference | Average Vol (30D) | Market Cap ($M) | Yield (%) | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
| HMPG | Hempshire Gr | 0.01 | 0.02 | 0.01 (109.5%) | 53903 | 0.8 | 0.0 | 0.0 |
| LOVE | Cannara Biotech | 0.71 | 1.35 | 0.64 (90.1%) | 27732 | 63.9 | 0.0 | 10.1 |
| TLRY | Tilray Brands | 2.44 | 4.02 | 1.58 (64.7%) | 1563867 | 1840.8 | 0.0 | 0.0 |
| TSND | TerrAscend | 2.00 | 3.23 | 1.23 (61.3%) | 161821 | 581.2 | 0.0 | 0.0 |
| OGI | OrganiGram Holdings | 2.18 | 3.35 | 1.17 (53.7%) | 269187 | 198.7 | 0.0 | 0.0 |
| HLS | HLS Therapeutics | 3.65 | 5.09 | 1.44 (39.4%) | 2793 | 116.6 | 1.4 | 0.0 |
| LABS | MediPharm Labs | 0.07 | 0.10 | 0.03 (33.3%) | 218621 | 30.3 | 0.0 | 0.0 |
| ROMJ | Rubicon Organics | 0.47 | 0.60 | 0.13 (28.2%) | 36262 | 27.1 | 0.0 | 0.0 |
| NDVA | Indiva | 0.04 | 0.05 | 0.01 (23.3%) | 176281 | 7.6 | 0.0 | 0.0 |
| MDP | Medexus Pharma | 1.78 | 2.00 | 0.22 (12.5%) | 45106 | 43.0 | 0.0 | 4.5 |
All data provided as of June 10, 2024.
The list is sorted by stocks with the greatest percentage difference between valuation and price.
HLS Therapeutics
HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company products include Clozaril, Vascepa, CSAN Pronto, and others. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, and the United States, and the Rest of the world.
HLS Therapeutics is listed under HLS on the Toronto Stock Exchange.
Stockcalc
StockCalc is a Canadian fintech company specializing in fundamental valuations for North American stocks and ETFs.
Stockcalc valuations (https://www.stockcalc.com/Resources) can help determine if a stock is undervalued. Stockcalc’s Weighted Average Valuation (WAV) is based on a proprietary calculation using model and analyst inputs, including:
- Discounted Cash Flow (DCF)
- Price & Other Comparables
- Multiples
- Adjusted Book Value (ABV)
- Analyst Consensus
Artificial Intelligence at Report on Business
Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.
